Likewise, AAA severity was higher in AngII-treated Apoe−/−Light−/− mice than in AngII-treated Apoe−/− mice, which did not exhibit type IV aneurysms (Figure 1c–e). This evidence concerns the gene AGT and triple-A syndrome.